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Background. Prolonged air leak is the major cause of morbidity after pulmonary resection. In 
this study we used in vitro and in vivo experiments to investigate an innovative approach based on 
the use of human umbilical cord blood platelet gel.
Materials and methods. In vitro, a scratch assay was performed to test the tissue repair capability 
mediated by cord blood platelet gel compared to the standard culture conditions using human primary 
mesothelial cells. In vivo, an iatrogenic injury was made to the left lung of 54 Wistar rats. Cord blood 
platelet gel was placed on the injured area only in treated animals and at different times histological 
changes and the presence of pleural adhesions were evaluated. In addition, changes in the pattern of 
soluble inflammatory factors were investigated using a multiplex proteome array.
Results. In vitro, mesothelial cell damage was repaired in a shorter time by cord blood platelet gel 
than in the control condition (24 versus 35 hours, respectively). In vivo, formation of new mesothelial 
tissue and complete tissue recovery were observed at 45±1 and 75±1 hours in treated animals and at 
130±2.5 and 160±6 hours in controls, respectively. Pleural adhesions were evident in 43% of treated 
animals compared to 17% of controls. No complications were observed. Interestingly, some crucial 
soluble factors involved in inflammation were significantly reduced in treated animals. 
Discussion. Cord blood platelet gel accelerates the repair of pleural damage and stimulates the 
development of pleural adhesions. Both properties could be particularly useful in the management 
of prolonged air leak, and to reduce inflammation.
Keywords: platelet gel, human cord blood, growth factors, pleural tissue, mesothelial cells.
Introduction
Prolonged air leak (PAL), defined as an air leak 
lasting longer than 7 days, is considered the most 
prevalent postoperative complication in thoracic surgery. 
Indeed, PAL is a common problem after pulmonary 
resection, occurring in 3-26% of such patients1. Relevant 
consequences are maintenance of chest drainages, 
prolonged hospital stay and increased postoperative 
morbidity (e.g. infections, emphysema). Consequently, 
this leads to higher hospital costs and major risks for 
the patient2.
Many studies have investigated what risk factors 
could predispose to the development of PAL: incomplete 
lobar fissures, pleural adhesions, lung diseases 
(emphysema, chronic obstructive lung disease, 
tuberculosis and fibrosis), patient's age (>75 years) and 
low diffusing capacity of the lung for carbon monoxide 
all seem strongly associated with PAL3,4.
The use of staplers as well as the introduction 
of new surgical techniques and proper management 
of chest drainage have contributed to a reduction in 
PAL5,6. Nevertheless, the pronounced clinical and 
economic impact of PAL promoted the development 
of a large variety of materials, such as natural/
synthetic glues7 and fibrin sealants obtained from 
platelet-poor plasma and rich in fibrinogen8; similarly, 
postoperative techniques, such as blood patches, have 
been proposed9. Surgical sealants are now widely 
used in cardiovascular and thoracic surgery, as well 
as in neurosurgery, mainly with one of the following 
objectives: to facilitate tissue adhesion, to support 
the surgical sutures and to promote haemostasis. 
Moreover, it has been proven that the use of surgical 
sealants reduces PAL, even though such sealants are 
not always able to shorten hospital stay. Platelet gel 
(PG) has been found to be an interesting and useful 
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product, rich in growth factors, supporting tissue 
regeneration in dentistry, oral-maxillofacial and bone 
surgery, wound healing and soft tissue injuries10-12 
and a relevant added value is that the costs associated 
with PG treatment amount to approximately one 
tenth of those associated with the use of advanced 
medications13. PG is composed of platelet-rich plasma 
mixed with thrombin and other activators such as 
calcium which promote both platelet degranulation 
and the coagulation cascade14. This process enriches 
PG in growth factors and bioactive substances that 
have been found to be effective in accelerating 
significant tissue repair and wound healing15. 
Usually PG is obtained from platelets derived from 
peripheral blood. Recently, some of us developed a 
patented procedure to obtain PG from umbilical cord 
blood (PCT WO/2010/007502) and showed that cord 
blood platelet gel (CBPG) contains factors more prone 
to support soft tissue repair compared to the PG from 
peripheral blood16.
In this study, in vitro and in vivo experimental 
approaches were used to test the efficacy of CBPG in 
the repair of pleural damage.
Materials and methods
In vitro experiments
Sample collection
Having obtained parental informed consent, cord 
blood (CB) units were collected into plastic bags 
containing 29 mL of citrate-phosphate-dextrose 
anticoagulant by trained midwives, before and after 
delivery of the placenta in cases of vaginal births and 
Caesarean sections, respectively. The units were stored 
at 2-22 °C and processed to obtain platelets within 24±2 
hours of collection.
Platelet gel preparation
The CB units were centrifuged at 550 g to sediment 
red and white cells and to concentrate most of the 
platelets in the supernatant plasma. They were then 
centrifuged at slow spin (100 g) in order to discard all 
the nucleated cells. The resulting platelet fraction was 
centrifuged at 2,000 g to obtain a platelet pellet and was 
then diluted in an appropriate volume of supernatant 
platelet-poor plasma to obtain a final concentration 
of 2×106 platelets/μL17(called platelet-rich plasma). 
Finally, the sample was let to stand for 30 minutes at 
room temperature and split into aliquots of 250 μL, 
which were stored at –20 °C until use. Before in vivo 
application, a single platelet-rich plasma aliquot was 
thawed at 37 °C and activated inside the same plastic 
device with a rounded shape of 1 cm diameter. In 
this way, the shape and the dimension of the gel were 
always the same within the whole experiment with 
a defined volume of 292 μL (250 μL of platelet-rich 
protein with 42 μL of calcium gluconate and batroxobin; 
Plateltex-Act, Plateltex, Bratislava, Slovakia). The 
gel consolidation was completed in approximately 10 
minutes. 
Platelet releasate preparation
The CBPG was centrifuged at 2,000 g to obtain the 
platelet releasate.
Mesothelial cell isolation
Samples of normal human pleural mesothelium 
(n =5) were obtained after informed consent from 
patients undergoing thoracic surgery procedures for 
non-oncological diseases.
Each tissue was washed with sterile phosphate-
buffered saline (PBS; EuroClone S.p.A., Pavia, Italy) + 
20% foetal bovine serum (FBS; Biochrom, AG, Berlin, 
Germany) and was then exposed to 1 mg/mL collagenase 
A (Roche Applied Science, Mannheim, Germany) for 
1 hour at 37 °C. The digestion was stopped using PBS 
+20% FBS and then the product was centrifuged at 
400 g for 10 minutes to collect the cells. The cells were 
cultured in M199 (Gibco Life Technologies, Carlsbad, 
CA, USA) supplemented with 20% FBS and 1% 
penicillin/streptomycin (P/S; Sigma Aldrich, St Louis, 
MO, USA) at 37 °C in a humidified atmosphere, at 5% 
CO2.
After 10 days of primary culture, when the attached 
cells reached confluence, they were harvested by 
treatment with TryPLE Select (Gibco Life Technologies), 
analysed by flow cytometry and used for the scratch 
assay (see below).
Flow cytometric analysis
Primary mesothelial cells were extensively 
characterised by flow cytometry to analyse their purity. 
Cells (5×105) were washed in PBS for 20 minutes at 
room temperature and incubated in the dark with the 
following conjugated mouse-anti human antibodies: 
CD24 FITC (StemCell Technologies Inc., Vancouver, 
Canada), CD49f FITC (StemCell Technologies Inc.), 
Cytokeratin 18 PE (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA), EpCAM FITC (StemCell Technologies 
Inc.), CD34 PE (Becton Dickinson, BD, San Josè, 
CA, USA), CD45 PC7 (Beckman Coulter, Fullerton, 
CA, USA), CD146 PE (Beckman Coulter) and von 
Willebrand factor FITC (Abcam, Cambridge, UK). 
The isotype immunoglobulins IgG1 PE-FITC (EMD 
Millipore Corporation, Billerica, MA, USA) and IgG1 
PC7 (Beckman Coulter) were used as negative controls 
under the same conditions. After staining, the cells 
were washed once with PBS. At least 50,000 events 
were acquired with a Cytomics FC500 flow cytometer 
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(Beckman Coulter) and plots were generated using the 
CXP analysis software. 
Scratch assay
Mesothelial cells were grown in six-well plates to a 
confluent monolayer. The cell monolayer was scraped 
in a straight line with a 200 μL pipette tip. Cell debris 
was removed by washing the cells once with PBS. Soon 
after the mesothelial cells were cultured with M199 plus 
20% CB platelet releasate or 20% FBS as control. Dishes 
were placed under a phase-contrast microscope and the 
first (baseline T0) image of the scratch was acquired. 
The cells were incubated at 37 °C for 35 hours and 
observed under a phase-contrast microscope (matching 
the reference point) at 8, 16, 24 and 35 hours.
In vivo experiments
Animals and treatments
Fifty-four male Wistar outbred rats (Charles River, 
Calco, Italy) weighing 200-250 g were used in the study. 
Rats were housed individually in a ventilated cage 
system (Tecniplast, Buguggiate, Italy), at 22±1 °C, with 
55±5% humidity, and a 12 hour dark/light cycle, with 
free access to food and water. All animals received care 
in compliance with the principles of laboratory animal 
care, and the guide for the care and use of laboratory 
animals (NIH publication n. 86-23, revised 1985); the 
Institutional Review Board approved the protocol. 
The same surgeons performed all the procedures, 
aseptically and under anaesthesia, using a combination 
of 100 mg/kg ketamine and 6 mg/kg xylazine injected 
intraperitoneally. 
The intubation technique described by Kastl et al.18 was 
partially modified: rats were positioned on an inclined 
cork board, suspended by a sling hooked to the upper 
incisors. After using lidocaine (Ecocain 10 g/100 mL 
spray), the vocal cords were reached by an otoscope 
(Heine mini 3000®, Heine, Herrsching, Germany); 
under vision a 22 cm wire guide was inserted and 
then an intravenous catheter (Abbocath 16 G x 1-1/4, 
Progressive Medical International, Vista, CA, USA) 
was introduced following Seldinger's technique. During 
surgery, rats were connected to a ventilator for small 
animals (SAR 830-p, CWE Inc., Ardmore, PA, USA) 
programmed at 55 breaths/min. 
Experimental design and surgery
Fifty-four animals were divided into two groups, a 
treated group and a control group, and a standardised 
single lesion was created on the left lung. In detail, 
after the operative field had been prepared and left 
hemithorax shaved, the animal was placed in right lateral 
decubitus. A thoracotomy incision of about 2.5 cm was 
performed in the third/fourth left intercostal space. Using 
a Beckmann's autostatic retractor, the pleural cavity was 
reached using a muscle sparing technique. Under direct 
vision a standardised lesion was created on the left lung 
parenchyma with a biopsy forcep (FB-56D-1, Olympus 
America Inc., Center Valley, USA) and scissors. 
In the control group (23 rats) after the injury a 16 
G chest tube was inserted and the incision was sutured 
with absorbable simple interrupted stitches 3/0 (Safil 
Quick 3/0, B. Braun, Melsungen, Germany). Only in 
the treatment group (31 rats) was CBPG placed on the 
injured area using a simple anatomical forceps. The 
appropriate position was double checked for 1 minute 
and then the animal was sutured as previously described 
for the control group. In each animal, the chest tube was 
connected to an underwater seal bottle at –2 cm H2O to 
allow correct lung expansion.
The time taken for the entire procedure was 
approximately 15-20 minutes per rat; no antibiotic 
was administered. The animals were extubated after 
regaining full ability to breathe spontaneously and then 
moved to the recovery room for the resumption of vital 
functions.
Sampling
The animals were sacrificed at different times. 
The rats were anaesthetised and put in the supine 
position. A laparotomic incision was performed and 
major abdominal vessels were severed. By a median 
sternotomy, the entire pleural cavity was carefully 
inspected, checking the hypothetical presence of 
anomalies. Free from any contact with the parietal 
pleura, pulmonary ligament and the hilum, the left lung 
was then completely excised and placed in formalin for 
the histological examination.
Histological evaluation
Before collecting the samples, a scale for the 
mesothelial cell recovery and pleural healing was defined 
a priori based on our previous experience in other animal 
models. This was the anatomopathological scale: grade 
A: surgical injury, grade B: strongly damaged (more than 
80% of denuded mesothelium), grade C: still evident 
damage (more than 50% of denuded mesothelium), 
grade D: initial lining (from 20% to 50% of denuded 
mesothelium), grade E: evident lining (less the 20% 
of denuded mesothelium), grade F: complete tissue 
repair (presence of mesothelial cells in all the damaged 
area). To avoid any influence by the operator, the blind 
histological assessment of the samples was performed 
twice by two independent observers. The damage was 
observed first at low magnification to identify the 
presence or absence of mesothelial lining. In a second 
step, the lesion was analysed at higher magnification 
(10X and 20X) and a score of injury was assigned based 
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on the defined scale. All specimens were formalin-fixed 
and paraffin-embedded. Three sections of 4-micron 
thickness were obtained from each paraffin block and 
stained with haematoxylin-eosin, Pass and Alcian blue.
Rat inflammatory profile
Before the rats were sacrificed, blood samples 
were collected 75 hours after the pleural damage and 
after CBPG treatment and then centrifuged at 900 g to 
collect sera.
The inflammatory profile was analysed in serum 
samples taken after pleural damage (n =4) and after 
CBPG treatment (n =6). The inflammatory cytokines 
in serum samples were detected by a multiplexed 
sandwich enzyme-linked immunosorbent assay 
(ELISA) that allows quantitative chemiluminescent 
measurement of nine proteins per well: interleukin-
1alpha (IL-1α), interleukin-1beta (IL-1β), interleukin-2 
(IL-2), interleukin-4 (IL-4), interleukin-6 (IL-6), 
interleukin-10 (IL-10), tumour necrosis factor-alpha 
(TNF-α), interferon-gamma (IFN-γ), granulocyte-
macrophage colony-stimulating factor (GM-CSF). 
The lower detection limits for these cytokines were 
1.6, 6, 6, 1.6, 6, 0.8, 6, 12 and 1.6 pg/mL, respectively 
(SearchLight Rat Cytokine 9-Plex Array, Aushon 
Biosystems, Billerica, MA, USA). 
Each well of the microplate was pre-spotted with 
target protein-specific antibodies and 50 μL of standards 
and samples were added to the plate for 1 hour at room 
temperature with shaking at 200 rpm. After washing the 
wells to remove unbound proteins, 50 μL of biotinylated 
antibodies were added to the plate for 30 min at room 
temperature with shaking at 200 rpm. Excess biotinylated 
antibody was washed away, and 50 μL of streptavidin-
horseradish peroxidase were added to the plate for 30 
minutes at room temperature with shaking at 200 rpm. 
In order to identify the signal, we used SuperSignal 
ELISA femto chemiluminescent substrate (Pierce, 
Rockford, IL, USA). The luminescent signal was 
recorded within 10 minutes using a cooled CCD camera 
and the amount of each target protein was analysed 
using Microsoft Excel 2000 as recommended by the 
manufacturers. 
Statistical analysis 
Results were analysed with Fisher's exact test, an 
unpaired t-test and the Cox test utilising JMP® software 
(SAS Institute Inc., SAS Campus Drive, Cary, NC, USA).
Results
In vitro experiments
Mesothelial cell characterisation
Mesothelial cells were characterised by the presence 
of classic cobblestone morphology, absence of CD24, 
epithelial/endothelial markers such as EpCAM, CD146 
and von Willebrand factor. They resulted negative for 
haematopoietic markers such as CD34 and CD45, and 
positive for cytokeratin 18 and CD49f. 
Evaluation of platelet releasate in the scratch assay
As previously reported16, CB platelet releasate 
contained the following factors: platelet-derived growth 
factors (PDGF-AB, PDGF-BB), transforming growth 
factor-beta1 (TGF-β1), basic fibroblast growth factor 
(bFGF), hepatocyte growth factor (HGF) and vascular 
endothelial growth factor (VEGF). A scratch assay was 
used to assess the effects of CB platelet releasate on 
mesothelial cell repair. The extent of regrowth to close 
the scratch wound was measured after 8, 16, 24, and 
35 hours of incubation in medium containing 20% CB 
platelet releasate or 20% FBS. The restoration of the 
full cellular density of mesothelium was faster with CB 
platelet releasate than with FBS. Indeed, wound closure 
was completed at 24 hours with CB platelet releasate, 
while it was repaired at 35 hours in the presence of FBS 
(P <0.0001) (Figure 1). 
Figure 1 - The effects of FBS and CB platelet releasate on mesothelial repair in a scratch assay. 
 (A) Reconstitution of mesothelial lining in the presence of FBS (standard condition, n =5) at T0, T8, T16, T24, 
T35; (B) Reconstitution of mesothelial lining in the presence of CB platelet releasate (n =5) at T0, T8, T16, T24; 
(C) Data are represented as mean ± SD. The P value was obtained performing an unpaired t-test. *P <0.0001.
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Inflammatory profile
The concentrations of some of inflammatory 
cytokines, including IL-2, IFN-γ and TNF-α, were 
statistically significantly different between the 
treatment group and the control group as shown in 
Figure 2, while the values of the remaining factors were 
either not statistically significant different or below the 
lower detection limit.
In vivo experiments
Pleural cavity
Neither infections nor other complications were 
observed during the experiment. The chest x-rays 
performed before the sacrifices showed correct 
parenchymal expansion, with no sign of pneumothorax 
or haemothorax in either groups. The pleural cavity 
was observed (Figure 3): pleural adhesions were found 
in 13 treated rats versus 4 control rats (Fisher's exact 
test, P =0.0505).
Histological examination
Figure 4 shows histological sections for the animals 
in the treated and control groups at different times. Some 
crucial features related to tissue damage and repair were 
analysed including subpleural damage characterised 
by marked haemorrhagic extravasation (Figures 4A 
and 4E), subpleural damage with scar-like component 
(Figure 4F), subpleural damage with visible new 
mesothelial lining (Figures 4B and 4G) and subpleural 
damage no longer visible with complete mesothelial 
repair (Figures 4C and 4H).
The correct application of the PG on the injured 
lung was verified by the anatomopathologist and using 
Alcian blue staining the gel matrix was visible outside 
the subpleural connective tissue corresponding to the 
injured area (Figure 4D).
A thin lining of mesothelial cells was observed on 
the injured area after 45±1 hours in the treatment group 
and after 130±2.5 hours in the control group (HR 0.468; 
P =0.0017). Complete tissue repair was observed after 
75±1 hours in the treatment group and after 160±6 hours 
in the control group.
Discussion
The development of PAL is a common complication 
that the thoracic surgeon has to face every day1. The 
persistence of parenchymal air leaks and residual pleural 
space may promote the development of several serious 
complications: an increase in the maintenance of pleural 
drainage associated with pain and immobilisation, 
the risk of developing pneumothorax, infection, 
bronchopleural fistula and, consequently, a prolongation 
of time spent in hospital2. 
The debate regarding the need for and appropriateness 
of new techniques to minimise intraoperative air leaks 
after lung surgery is still ongoing even though many 
experimental attempts have been made and several 
studies have been published. 
The routine use of surgical staplers has strongly 
decreased the incidence of this complication as have 
fissureless techniques for lobectomy and pleural 
tenting. In addition, reinforcement of the staple line 
with bovine pericardium or synthetic materials has 
been prophylactically used with success in patients 
with emphysematous lungs5,6. Moreover, alternative 
methods, such as surgical sealants of various origins, 
can be used effectively7,8. A recent review evaluated 16 
randomised controlled trials that had investigated the 
role of surgical sealants for preventing air leaks after 
pulmonary resections: fibrin glue and an autologous 
fibrin sealant (Vivostat®, A/S, Alleroed, Denmark) were 
used in six and one trials, respectively; different synthetic 
biodegradable sealants based on polyethylenglycol were 
tested in five trials; absorbable patches coated with 
human fibrinogen and human thrombin (TachoSil®, 
Figure 2 - TNF-α, IFN-γ and IL-2 concentrations in rat sera 
at 75 hours after pleural damage (control group, 
CG) and after CBPG treatment (treatment group, 
TG). Inflammatory factors were measured by 
proteome assay (pg/mL; CG n =4, TG n =6; median 
and range). The P value was obtained performing 
an unpaired t-test. *P <0.0001;  **P <0.0003.
Figure 3 - Presence of a pleural adhesion on the thoracotomy.
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Takeda Pharmaceuticals International GmbH, Zurich, 
Switzerland) were used in four studies19. Interestingly, 
in 12 of these trials there was a statistically significant 
difference in reduction of air leaks in treated patients 
but only in three of them was there an advantage in 
terms of reduction of hospital stay. However, most of 
the studies present involved small cohorts of patients 
and did not, therefore, allow definitive conclusions.
In this context, new biological or synthetic 
materials, able to obtain better control of air leaks, 
are still needed. In recent years, the autologous blood 
patch has been demonstrated to be an effective, cheap, 
readily available and well-tolerated treatment for 
PAL. Its effect seems to be achieved by direct clot 
formation and subsequently the fibrogenic activity of 
the blood creates a pleurodesis via pleural irritation 
and inflammation. However, the most controversial 
issue is the amount of blood required for successful 
pleurodesis. Several authors are concerned about 
using large volumes of blood, which is considered 
an ideal culture medium for bacteria; nevertheless a 
recent review reported high rates of success with large 
volumes of blood applied during the procedure (about 
150 mL)8.
Analysing these available but still controversial 
results, a first consideration that can be made is that 
the expected effects of these treatments are largely 
based on their mechanical properties and generally no 
growth support is given to the damaged tissue to rapidly 
and efficiently reconstitute the mesothelial lining. In 
fact, growth factors, which help and support tissue 
regeneration and could be crucial in pleural healing, are 
missing from all these treatments. It is exactly in this 
context that an innovative approach such as platelet gel 
can be envisioned to combine mechanical properties and 
growth factor release. In fact, it has been extensively 
demonstrated that platelets can release several growth 
factors contained in their granules such as PDGF-AB, 
PDGF-BB, TGF-b1, bFGF, HGF and VEGF12,15,20. 
In this study on mesothelial repair we tested an 
innovative product, CBPG, which not only provides 
optimal mechanical support and growth factors but 
which also contains a combination of growth factors/
cytokines more appropriate for tissue repair than the 
PG obtained from peripheral blood16. 
Our in vitro results clearly show that CBPG 
efficiently restores PAL damage and in a shorter time 
than that taken for spontaneous repair.
Another effect of CBPG, and by no means the 
least important one, is the reduction of some crucial 
inflammatory factors such as IL-2, TNF-α and IFN-γ, 
which are well-known to be highly involved in 
inflammation processes including wound healing21,22. 
The success of wound healing depends on a balance 
Figure 4 -  Histological sections of rat lung in the two different groups. 
 On the left side the treated animals: (A) recent subpleural damage characterised by marked haemorrhagic extravasation, fibrin-
rich clot bleeding associated with acute and chronic inflammation and fibroblast hyperplasia; (B) subpleural damage with 
a visible new mesothelial lining; (C) subpleural damage no longer visible. Complete mesothelial repair; (D) late subpleural 
damage in presence of weakly basophilic material due to Alcian blue 8GX staining. On the right side the controls: (E) recent 
subpleural damage characterised by marked haemorrhagic extravasation, fibrin-rich clot bleeding associated with acute 
inflammation; (F) subpleural damage with leucocyte-fibrin clot associated with scattered scar-like components; (G) subpleural 
damage in an advanced stage of mesothelial tissue repair; (H) subpleural damage no longer visible. Complete mesothelial r epair.
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between growth factors for tissue repair and a reduction 
of inflammatory factors.
All of these properties were well demonstrated in our 
in vivo animal model. Although there are already some 
studies in the literature about parenchymal lung damage 
in rats23, we developed a new experimental approach: 
after anaesthesia and intubation, a standardised injury 
was made on the left lung with biopsy forceps in order 
to obtain better defined and more reproducible pleural 
damage.
According to the histological analysis, the results 
were definitely better with CBPG than in the control 
group not only regarding the formation of the first 
mesothelial lining (–60%; P =0.0017), but also in 
complete tissue repair (–57%). The representative trend 
of tissue repair is clearly shown in Figure 5.
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